News

UK start-up Breathing Buildings rethinks natural ventilation

MEPs reached a tentative compromise with Member States this week on the Single Patent. All that’s needed now is for EU ministers give the proposal a nod in December and for the European Parliament to vote yes too

Experts say cutting embryonic stem cell funding in Horizon 2020 will threaten progress Europe is making in developing safe, effective and well-regulated cell therapies - and in creating an economically important regenerative medicine sector

Europe currently leads the world in therapeutic applications of regenerative medicine. It has seen companies spin out from universities and approved products reaching the market. Science|Business brought together experts to discuss how to build on these foundations

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue

The EU must continue to support human embryonic stem cell research to maintain its lead in regenerative medicine. The upcoming Irish Presidency needs to recognise the importance of this research and resist calls for a ban on funding in Horizon 2020

As part of the Science|Business Special Report on stem cell research, experts give their opinion on the much debated topic

Spin-out Liquid Light builds on research results that languished in the lab for 10 years – reverse combustion process produces methanol from CO2. Next step: industrial scale production.

Is a frozen “rollover” budget for 2013 and beyond now likely? MEPs debate the EU budget at a Science|Business event, as negotiations between Parliament and Council collapse

Interview with Professor David Zilberman, professor of agricultural and resource economics at the University of California, Berkeley and principal investigator at the UC Berkeley Energy Biosciences Institute